Patents by Inventor Blair Jackson

Blair Jackson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pulmonary delivery for levodopa
    Patent number: 8586093
    Abstract: In one aspect, the invention is related to a method of treating a patient with Parkinson's disease, the method including administering to the respiratory tract of the patient particles that include more than about 90 weight percent (wt %) of levodopa. The particles are delivered to the patient's pulmonary system, preferably to the alveoli or the deep lung.
    Type: Grant
    Filed: February 21, 2013
    Date of Patent: November 19, 2013
    Assignee: Civitas Therapeutics
    Inventors: Blair Jackson, David J. Bennett, Raymond T. Bartus, Dwaine F. Emerich
  • Pulmonary delivery for levodopa
    Patent number: 8404276
    Abstract: In one aspect, the invention is related to a method of treating a patient with Parkinson's disease, the method including administering to the respiratory tract of the patient particles that include more than about 90 weight percent (wt %) of levodopa. The particles are delivered to the patient's pulmonary system, preferably to the alveoli or the deep lung.
    Type: Grant
    Filed: December 20, 2010
    Date of Patent: March 26, 2013
    Assignee: Civitas Therapeutics, Inc.
    Inventors: Blair Jackson, David J. Bennett, Raymond T. Bartus, Dwaine F. Emerich
  • Pulmonary Delivery for Levodopa
    Publication number: 20110151008
    Abstract: In one aspect, the invention is related to a method of treating a patient with Parkinson's disease, the method including administering to the respiratory tract of the patient particles that include more than about 90 weight percent (wt %) of levodopa. The particles are delivered to the patient's pulmonary system, preferably to the alveoli or the deep lung.
    Type: Application
    Filed: December 20, 2010
    Publication date: June 23, 2011
    Applicant: Alkermes, Inc.
    Inventors: Blair Jackson, David J. Bennett, Raymond T. Bartus, Dwaine F. Emerich
  • Pulmonary delivery for levodopa
    Patent number: 7879358
    Abstract: In one aspect, the invention is related to a method of treating a patient with Parkinson's disease, the method including administering to the respiratory tract of the patient particles that include more than about 90 weight percent (wt %) of levodopa. The particles are delivered to the patient's pulmonary system, preferably to the alveoli or the deep lung.
    Type: Grant
    Filed: March 19, 2003
    Date of Patent: February 1, 2011
    Assignee: Alkermes, Inc.
    Inventors: Blair Jackson, David J. Bennett, Raymond T. Bartus, Dwaine F. Emerich
  • Method and apparatus for producing dry particles
    Publication number: 20080108554
    Abstract: Method and apparatus for producing dry particles. Two liquid components are combined in a static mixer, atomized into droplets, and the droplets dried to form dry particles. Use of the static mixer enables incompatible liquid components to be rapidly and homogeneously combined. The present invention optimizes process conditions for increasing and controlling particle porosity. The present invention also allows for optimization of particle size in real-time during particle production.
    Type: Application
    Filed: January 4, 2008
    Publication date: May 8, 2008
    Applicant: Alkermes, Inc.
    Inventors: Blair Jackson, Lloyd Johnston, Ernest Penachio, Charles Blizzard, Marie Chung, Jean Sung
  • Manufacture of particles for pulmonary drug delivery by carbon dioxide assisted nebulization
    Publication number: 20060105051
    Abstract: Methods of making porous particles by using carbon dioxide assisted nebulization (CAN) technology in combination with spray drying technologies are disclosed. As the mixture of carbon dioxide (CO2) and the solvent with drug matrix is expanded through the nebulizer to atmospheric conditions, the resulting aerosol contains fine micro-bubbles and/or micro-droplets that contains dissolved CO2 which is co-currently fed into a spray drying chamber.
    Type: Application
    Filed: October 27, 2005
    Publication date: May 18, 2006
    Inventors: Blair Jackson, David Bennett, Donghao Chen, Michael Lipp, Purav Dave
  • Method and apparatus for producing dry particles
    Publication number: 20060039987
    Abstract: Method and apparatus for producing dry particles. Two liquid components are combined in a static mixer, atomized into droplets, and the droplets dried to form dry particles. Use of the static mixer enables incompatible liquid components to be rapidly and homogeneously combined. The present invention optimizes process conditions for increasing and controlling particle porosity. The present invention also allows for optimization of particle size in real-time during particle production.
    Type: Application
    Filed: October 24, 2005
    Publication date: February 23, 2006
    Applicant: Advanced Inhalation Research, Inc.
    Inventors: Richard Batycky, Blair Jackson, Lloyd Johnston, Jeffrey Mintzes, Ernest Penachio
  • Method for administration of growth hormone via pulmonary delivery
    Publication number: 20050163725
    Abstract: The claimed invention relates to a method of treating a human patient with growth hormone deficiency or a non-growth hormone deficiency disorder treatable with hGH, which comprises administering human growth hormone to the deep lung to said patient by a pulmonary device.
    Type: Application
    Filed: July 28, 2004
    Publication date: July 28, 2005
    Inventors: Charles Blizzard, John Chipman, Gordon Cutler, Blair Jackson, Lloyd Johnston, Richard Lucas, Jeffrey Mintzes
  • Pulmonary delivery for levodopa
    Publication number: 20040018989
    Abstract: In one aspect, the invention is related to a method of treating a patient with Parkinson's disease, the method including administering to the respiratory tract of the patient particles that include more than about 90 weight percent (wt %) of levodopa. The particles are delivered to the patient's pulmonary system, preferably to the alveoli or the deep lung.
    Type: Application
    Filed: March 19, 2003
    Publication date: January 29, 2004
    Applicant: Advanced Inhalation Research, Inc.
    Inventors: Blair Jackson, David J. Bennett, Raymond T. Bartus, Dwaine F. Emerich
  • hGH (human growth hormone) formulations for pulmonary administration
    Publication number: 20040009231
    Abstract: This invention relates to the administration of proteins by absorption from the lungs. In particular, it is concerned with providing therapeutic doses of human growth hormone to the bloodstream without irritating or otherwise damaging lung tissue. This invention also relates to the methods of delivery of human growth hormone to the pulmonary system.
    Type: Application
    Filed: March 19, 2003
    Publication date: January 15, 2004
    Applicant: Advanced Inhalation Research, Inc.
    Inventors: Blair Jackson, Lloyd Johnston, Charles D. Blizzard, Jeffrey Mintzes
  • Pulmonary delivery for levodopa
    Patent number: RE43711
    Abstract: In one aspect, the invention is related to a method of treating a patient with Parkinson's disease, the method including administering to the respiratory tract of the patient particles that include more than about 90 weight percent (wt %) of levodopa. The particles are delivered to the patient's pulmonary system, preferably to the alveoli or the deep lung.
    Type: Grant
    Filed: October 17, 2011
    Date of Patent: October 2, 2012
    Assignee: Civitas Therapeutics, Inc.
    Inventors: Blair Jackson, David J. Bennett, Raymond T. Bartus, Dwaine F. Emerich